Because of pioneering work in the biomedical sciences, some seizures can now be prevented and many can be treated. However, not all cases can be treated effectively and many people continue to suffer as a result. Also, existing treatments produce adverse effects in many patients. Despite the progress which has been made to this point in time, approximately 1 out of 11 people experience a seizure sometime during life. Epilepsy is still one of the most common neurological disorders affecting mankind.
Many children suffer from the epilepsies.
Pravin Mishra, Ph.D., became a faculty member in the DBTS in 1992. He has pioneered and patented sophisticated new technologies for investigating minute changes in brain chemistry and function in intact animal models of human disease. His innovations have been decisive in enabling himself and other faculty members to achieve international reputations for their scientific accomplishments. Epilepsy research in the DBTS is designed to answer key questions which will enable the development of new treatments. Our research program is also being undertaken to reduce the occurrence of adverse effects of current treatments.